Nested Case–Control Study of Corin Combined with sFlt-1/PLGF in Predicting the Risk of Preeclampsia

Nested Case–Control Study of Corin Combined with sFlt-1/PLGF in Predicting the Risk of Preeclampsia

Mei Liu,1,2 Rui-Bo Wang,1 Jian-Hong Xing,2 Ying-Xue Tang3 1Chinese Medicine College, Shandong University of Traditional Chinese Medicine, Jinan, 250355, Shandong, People’s Republic of China; 2Department of Obstetrics, Affiliated Hospital of Shandong University of Traditional Chinese Medici...

Full description

Bibliographic Details
Main Authors:	Liu M, Wang RB, Xing JH, Tang YX
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-06-01
Series:	International Journal of General Medicine
Subjects:	preeclampsia corin soluble vascular endothelial growth factor receptor-1 placental growth factor prediction
Online Access:	https://www.dovepress.com/nested-casecontrol-study-of-corin-combined-with-sflt-1plgf-in-predicti-peer-reviewed-fulltext-article-IJGM

Similar Items

A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
by: Vivek Pant, et al.
Published: (2019-07-01)

Decision Threshold for Kryptor sFlt‐1/PlGF Ratio in Women With Suspected Preeclampsia: Retrospective Study in a Routine Clinical Setting
by: Lise Lotte Torvin Andersen, et al.
Published: (2021-09-01)

Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration
by: Ignacio Herraiz, et al.
Published: (2015-08-01)

Expression of placental growth factor mRNA in preeclampsia
by: Pooneh Nikuei, et al.
Published: (2017-05-01)

sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics
by: Viktorija Tarasevičienė, et al.
Published: (2016-01-01)

Trophoblast-Targeted Nanomedicine Modulates Placental sFLT1 for Preeclampsia Treatment
by: Lei Li, et al.
Published: (2020-02-01)

Role of RNA Processing Factors in the Expression of Flt-1 and its Secreted Variant, sFlt-1
by: Roche, Rebecca I.
Published: (2014)

Nephrotic syndrome due to preeclampsia before 20 weeks of gestation: a case report
by: Tomo Suzuki, et al.
Published: (2020-06-01)

Preeclampsia: Maternal Systemic Vascular Disorder Caused by Generalized Endothelial Dysfunction Due to Placental Antiangiogenic Factors
by: Takuji Tomimatsu, et al.
Published: (2019-08-01)

Enhanced Serum Levels of sFlt1: Impact on Materno–Fetal CMV Transmission
by: Lukas Penka, et al.
Published: (2020-04-01)

Maternal Serum Concentrations of Corin, Endoglin, PP13, and sFlt-1 and their Changes with Advancement of Pregnancy and Correlation with Doppler of Uterine Arteries
by: Chalova Krasimira I., et al.
Published: (2018-12-01)

PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms
by: Karin Zins, et al.
Published: (2016-09-01)

Correlation of STAT4 and STAT6 expression levels in preeclampsia placenta with sFlt-1 and ADMA generation as well as placental hypoxia
by: Dong-Mei Su
Published: (2016-09-01)

Are the Cognitive Alterations Present in Children Born From Preeclamptic Pregnancies the Result of Impaired Angiogenesis? Focus on the Potential Role of the VEGF Family
by: Evelyn Lara, et al.
Published: (2018-11-01)

RELATION OF PLGF IN THE FIRST TRIMESTER TO FETAL SGA OR IUGR
by: Ismaili Bashkim
Published: (2019-12-01)

Elevated VEGF-A & PLGF concentration in aqueous humor of patients with uveal melanoma following Iodine-125 plaque radiotherapy
by: Meng-Xi Chen, et al.
Published: (2020-04-01)

Correlation of urine sFlt-1/PLGF ratio with abnormal trophoblast invasion and apoptosis in pregnant women with preeclampsia
by: Xi-Ping Hong, et al.
Published: (2018-07-01)

Short-Term Prediction of Preeclampsia in Chinese Women Using the Soluble fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio: A Sub-Analysis of the PROGNOSIS Asia Study
by: Jinsong Gao, et al.
Published: (2021-08-01)

Micro- and Nano-vesicles from First Trimester Human Placentae Carry Flt-1 and Levels Are Increased in Severe Preeclampsia
by: Mancy Tong, et al.
Published: (2017-07-01)

Diagnostic accuracy of placental growth factor (PIGF) in pre-eclampsia- A case control study
by: Sangappa Kashinakunti, et al.
Published: (2020-01-01)

Gut microbiota changes in preeclampsia, abnormal placental growth and healthy pregnant women
by: Lihui Huang, et al.
Published: (2021-10-01)

Preeclampsia: Novel Mechanisms and Potential Therapeutic Approaches
by: Zaher Armaly, et al.
Published: (2018-07-01)

Placental growth factor for the prognosis of women with preeclampsia (fullPIERS model extension): context matters
by: U. Vivian Ukah, et al.
Published: (2020-11-01)

Analysis of Methyldopa Therapy on sFlt-1 Antiangiogenic Levels in Patients with Severe Preeclampsia
by: Teri Wina Herwati, et al.
Published: (2018-04-01)

Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks’ gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study
by: Teresa M. MacDonald, et al.
Published: (2018-08-01)

Risks associated with preeclampsia: possible mechanisms
by: Bentolhoda Sahebnasagh, et al.
Published: (2017-01-01)

PlGF Reduction Compromises Angiogenesis in Diabetic Foot Disease Through Macrophages
by: Lingyan Zhu, et al.
Published: (2021-09-01)

Maternal Serum Placental Growth Factor, Soluble Fms-Like Tyrosine Kinase-1, and Soluble Endoglin in Twin Gestations and the Risk of Preeclampsia—A Systematic Review
by: Katarzyna Kosinska-Kaczynska, et al.
Published: (2020-01-01)

Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
by: Dietmar Schlembach, et al.
Published: (2018-08-01)

Combined Anti-PLGF and Anti-Endostatin Treatments Inhibit Ocular Hemangiomas
by: Hua Jiang, et al.
Published: (2015-06-01)

The Use of Biochemical and Biophysical Markers in Early Screening for Preeclampsia in Mongolia
by: Urjindelger Tserensambuu, et al.
Published: (2018-07-01)

Inhibition of Ocular Neovascularization by Co-Inhibition of VEGF-A and PLGF
by: Xiaochuan Huo, et al.
Published: (2015-03-01)

High Level of Soluble FMS-Like Tyrosine Kinase-1 (sFlt-1) Serum in Pregnancy as a Risk Factor of Preeclampsia
by: I Gede Mega Putra, et al.
Published: (2016-07-01)

Circulating Levels of sFlt1 Splice Variants as Predictive Markers for the Development of Preeclampsia
by: Colby A. Souders, et al.
Published: (2015-06-01)

Taiwanese new direction in prediction of early pregnancy preeclampsia
by: Yen-Tin Chen, et al.
Published: (2021-01-01)

The Effects of Endoglin and Placental Growth Factor on the Pathophysiology of Preeclampsia
by: Berger, Sarah E.
Published: (2018)

sFlt-1, Not PlGF, Is Related to Twin Gestation Choronicity in the First and Third Trimesters of Pregnancy
by: Szymon Kozłowski, et al.
Published: (2021-06-01)

Serum Soluble Fms-Like Tyrosine Kinase 1 (sFlt-1) Predicts the Severity of Acute Pancreatitis
by: Paulina Dumnicka, et al.
Published: (2016-12-01)

Diagnostic accuracy of sFlt1/PlGF ratio as a marker for preeclampsia
by: Pooneh Nikuei, et al.
Published: (2020-02-01)

The role of angiogenic factors in endometrial cancer
by: Monika Magdalena Żyła, et al.
Published: (2014-05-01)